PRGO

Perrigo Company plc NYSE

Healthcare ·Drug Manufacturers - Specialty & Generic ·IE · perrigo.com

$11.92

After hrs $11.39 -0.09%

Mkt Cap $1.7B

52w Low $9.23 14.0% of range 52w High $28.44

50d MA $11.30 200d MA $17.01

P/E (TTM) -1.2x

EV/EBITDA -6.7x

P/B 0.6x

Debt/Equity 1.4x

ROE -48.6%

P/FCF 13.3x

RSI (14) —

ATR (14) —

Beta 0.49

50d MA $11.30

200d MA $17.01

Avg Volume 3.3M

About

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, ma…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 26, 2026	AMC	0.80	0.77	-3.8%	14.19	-0.9%	-6.8%	-13.0%	-19.7%	-17.6%	-21.1%	-31.5%	—
Nov 5, 2025	AMC	0.75	0.80	+6.7%	15.10	+0.8%	-1.1%	-4.4%	-5.6%	-5.3%	-6.2%	-11.0%	—
Aug 6, 2025	AMC	0.59	0.57	-3.4%	23.61	+0.6%	-3.3%	-4.5%	-6.7%	-2.3%	+0.2%	-4.1%	—
May 7, 2025	AMC	0.56	0.60	+7.1%	26.41	-0.6%	+1.5%	+2.3%	+2.2%	-0.7%	-1.5%	-0.9%	—
Feb 27, 2025	AMC	0.92	0.93	+1.1%	24.13	+14.6%	+20.2%	+20.2%	+21.4%	+22.1%	+18.9%	+16.2%	—
Nov 6, 2024	AMC	0.82	0.81	-1.2%	27.31	+0.5%	-1.4%	-3.5%	-2.2%	-3.4%	-1.8%	+2.8%	—
Aug 2, 2024	AMC	0.48	0.53	+10.4%	27.58	-3.9%	+4.1%	+2.9%	+0.7%	+1.2%	-2.4%	+3.6%	—
May 7, 2024	AMC	0.24	0.29	+20.8%	30.15	+0.5%	+3.2%	+2.9%	+1.9%	+2.2%	+0.5%	-10.4%	—
Feb 27, 2024	AMC	0.83	0.86	+3.6%	27.30	+0.0%	-3.3%	-3.8%	-3.6%	-3.9%	-0.1%	+17.9%	—
Nov 7, 2023	AMC	0.65	0.64	-1.5%	29.62	+0.0%	-2.0%	-5.2%	-4.1%	-4.9%	-2.5%	+3.1%	—
Aug 8, 2023	AMC	0.54	0.63	+16.7%	39.94	-1.1%	-2.5%	-3.6%	-1.1%	-2.4%	-2.7%	-15.6%	—
May 9, 2023	AMC	0.42	0.45	+7.1%	34.88	+0.3%	+4.5%	+1.8%	+0.9%	-1.9%	-5.8%	-3.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 27	Canaccord Genuity	Maintains	Buy → Buy	—	$14.19	$14.06	-0.9%	-6.8%	-13.0%	-19.7%	-17.6%	-21.1%
Dec 15	JP Morgan	Maintains	Neutral → Neutral	—	$13.14	$13.15	+0.1%	-2.3%	-0.9%	+1.7%	+1.3%	+0.7%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$15.10	$15.22	+0.8%	-1.1%	-4.4%	-5.6%	-5.3%	-6.2%
Nov 6	JP Morgan	Downgrade	Overweight → Neutral	—	$15.10	$15.22	+0.8%	-1.1%	-4.4%	-5.6%	-5.3%	-6.2%
Oct 27	Jefferies	Maintains	Hold → Hold	—	$21.46	$21.46	+0.0%	+2.2%	+0.7%	-0.8%	-3.8%	-3.4%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$23.61	$23.75	+0.6%	-3.3%	-4.5%	-6.7%	-2.3%	+0.2%
Aug 7	Canaccord Genuity	Maintains	Buy → Buy	—	$23.61	$23.75	+0.6%	-3.3%	-4.5%	-6.7%	-2.3%	+0.2%
Jan 6	Piper Sandler	Downgrade	Overweight → Neutral	—	$25.95	$25.70	-1.0%	-2.4%	-3.9%	-3.5%	-6.1%	-6.2%
Sep 30	Canaccord Genuity	Maintains	Buy → Buy	—	$25.65	$25.68	+0.1%	+2.3%	-0.7%	-2.2%	-3.5%	-2.8%
Sep 23	Jefferies	Downgrade	Buy → Hold	—	$27.13	$27.17	+0.1%	-0.3%	-2.2%	-5.8%	-5.5%	-5.5%
Jul 11	Piper Sandler	Maintains	Overweight → Overweight	—	$27.16	$27.20	+0.1%	+2.5%	+1.2%	-1.0%	-0.3%	+2.1%
Jun 13	Piper Sandler	Maintains	Overweight → Overweight	—	$27.84	$27.48	-1.3%	-1.6%	-3.6%	-5.8%	-8.2%	-8.0%
Apr 12	Canaccord Genuity	Maintains	Buy → Buy	—	$31.28	$31.24	-0.1%	-3.1%	-3.7%	-4.2%	-4.0%	-4.3%
Apr 8	Piper Sandler	Maintains	Overweight → Overweight	—	$31.40	$31.70	+1.0%	+1.1%	+2.6%	+0.4%	-0.4%	-3.4%
Feb 28	JP Morgan	Maintains	Overweight → Overweight	—	$27.30	$27.31	+0.0%	-3.3%	-3.8%	-3.6%	-3.9%	-0.1%
Aug 9	JP Morgan	Maintains	Overweight → Overweight	—	$39.94	$39.51	-1.1%	-2.5%	-3.6%	-1.1%	-2.4%	-2.7%
Mar 7	Canaccord Genuity	Maintains	Buy → Buy	—	$36.96	$37.24	+0.8%	+2.0%	+0.3%	-1.7%	-3.0%	-4.6%
Mar 6	Raymond James	Maintains	Outperform → Outperform	—	$38.75	$38.51	-0.6%	-4.6%	-2.7%	-4.4%	-6.2%	-7.5%
Nov 9	Raymond James	Maintains	Outperform → Outperform	—	$33.26	$32.93	-1.0%	-3.5%	-1.3%	+0.5%	-1.9%	-1.5%
Sep 14	Argus	Upgrade	Hold → Buy	—	$39.33	$39.92	+1.5%	+1.8%	+1.0%	+2.0%	+2.6%	+1.4%
Sep 6	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$36.74	$37.87	+3.1%	+3.3%	+4.4%	+5.1%	+6.6%	+10.8%
May 4	Raymond James	Maintains	Outperform → Outperform	—	$33.24	$33.07	-0.5%	+0.0%	-2.8%	-2.3%	-3.1%	-2.8%
Nov 11	Raymond James	Maintains	Outperform → Outperform	—	$42.21	$41.73	-1.1%	+2.6%	+2.6%	+1.3%	+1.8%	+1.3%
Oct 14	Raymond James	Upgrade	Market Perform → Outperform	—	$44.86	$45.64	+1.7%	+1.4%	-0.3%	-0.2%	+1.8%	+2.0%
Sep 30	Jefferies	Upgrade	Hold → Buy	—	$43.50	$50.73	+16.6%	+8.8%	+11.6%	+10.6%	+11.3%	+11.5%
Mar 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$40.57	$40.76	+0.5%	+1.2%	+3.1%	+0.9%	+2.6%	+1.9%
Jan 6	RBC Capital	Downgrade	Outperform → Sector Perform	—	$44.27	$43.48	-1.8%	+1.3%	+3.9%	+0.8%	+0.7%	+3.2%
Oct 28	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$44.03	$43.23	-1.8%	-3.3%	-3.4%	-0.4%	+3.6%	+3.0%
Sep 17	SVB Leerink	Maintains	Outperform → Outperform	—	$49.84	$46.92	-5.9%	-2.9%	-5.6%	-7.9%	-6.6%	-9.0%
Jun 8	SVB Leerink	Maintains	Outperform → Outperform	—	$55.61	$55.62	+0.0%	+3.8%	+0.6%	-3.9%	-7.9%	-7.4%
Apr 17	Argus	Downgrade	Buy → Hold	—	$50.84	$51.49	+1.3%	+2.0%	+0.0%	-2.3%	-2.4%	+0.3%
Apr 2	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$45.11	$44.00	-2.5%	-5.1%	-1.7%	+5.5%	+4.4%	+8.3%
Mar 24	JP Morgan	Upgrade	Neutral → Overweight	—	$42.27	$45.01	+6.5%	+7.0%	+5.9%	+10.1%	+9.1%	+15.5%
Mar 20	SVB Leerink	Upgrade	Market Perform → Outperform	—	$43.75	$44.14	+0.9%	-3.7%	-3.4%	+3.3%	+2.3%	+6.4%
Mar 11	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$49.48	$48.05	-2.9%	-7.0%	-17.8%	-6.4%	-7.9%	+0.3%
Jan 21	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$59.02	$58.77	-0.4%	+1.4%	+0.8%	+0.8%	-0.4%	-0.6%
Oct 11	Argus	Upgrade	Hold → Buy	—	$52.00	$53.00	+1.9%	+2.8%	+2.0%	+3.5%	+3.7%	+4.6%
Sep 30	Wells Fargo	Maintains	Market Perform → Market Perform	—	$54.98	$55.19	+0.4%	+1.7%	+0.4%	-1.5%	-3.3%	-2.5%
Sep 25	SunTrust Robinson Humphrey	Maintains	Hold → Hold	—	$54.25	$54.26	+0.0%	+1.8%	-0.5%	+1.3%	+3.0%	+1.8%
Mar 26	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$46.77	$45.93	-1.8%	+1.4%	+2.3%	+1.3%	+3.0%	+4.9%
Mar 20	SunTrust Robinson Humphrey	Maintains	Hold → Hold	—	$49.24	$49.09	-0.3%	-1.8%	-1.3%	-4.0%	-5.0%	-3.7%
Dec 21	Wells Fargo	Maintains	Market Perform → Market Perform	—	$52.36	$44.45	-15.1%	-29.3%	-30.3%	-22.3%	-24.3%	-23.8%
Nov 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$65.58	$65.04	-0.8%	-0.3%	-3.2%	-3.2%	-3.5%	-4.3%
Nov 13	Berenberg	Downgrade	Buy → Hold	—	$65.58	$65.04	-0.8%	-0.3%	-3.2%	-3.2%	-3.5%	-4.3%
Aug 21	Wells Fargo	Maintains	Market Perform → Market Perform	—	$75.49	$74.42	-1.4%	-1.9%	-1.4%	-2.0%	-1.6%	-1.1%
Aug 10	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$70.03	$69.01	-1.5%	-0.2%	-0.6%	-0.8%	-0.8%	+0.5%
Aug 10	JP Morgan	Maintains	Neutral → Neutral	—	$70.03	$69.01	-1.5%	-0.2%	-0.6%	-0.8%	-0.8%	+0.5%
Aug 10	Deutsche Bank	Downgrade	Buy → Hold	—	$70.03	$69.01	-1.5%	-0.2%	-0.6%	-0.8%	-0.8%	+0.5%
Jul 30	Argus	Downgrade	Buy → Hold	—	$78.49	$78.38	-0.1%	+2.1%	+2.6%	+1.0%	-0.3%	+0.3%
Jul 12	Goldman Sachs	Downgrade	Neutral → Sell	—	$77.72	$75.72	-2.6%	-2.2%	-2.3%	-3.4%	+0.4%	-1.7%

Recent Filings

8-K · 8.01 !! High

PERRIGO COMPANY PLC -- 8-K 8.01: Material Event / Announcement

Perrigo Company reclassified its Dermacosmetics business from the Skin Care Category to a separate reporting segment, providing investors clearer visibility into this business unit's financial performance and operational metrics.

Apr 22

8-K · 1.01 ! Medium

Unknown — 8-K 1.01: Financing / Debt Agreement

Perrigo secured a $200 million financing arrangement, strengthening its liquidity position and reducing near-term refinancing risk, which should stabilize the stock amid any debt maturity concerns.

Mar 23

8-K

PERRIGO COMPANY PLC -- 8-K Filing

Perrigo Company is providing adjusted financial measures to offer investors greater insight into management's operational assessment and planning methodology for evaluating business performance.

Feb 26

Data updated apr 26, 2026 8:38pm · Source: massive.com